 |
PDBsum entry 4u0q
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
4u0q
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structure of malaria invasion protein rh5 with erythrocyte basigin and blocking antibodies.
|
 |
|
Authors
|
 |
K.E.Wright,
K.A.Hjerrild,
J.Bartlett,
A.D.Douglas,
J.Jin,
R.E.Brown,
J.J.Illingworth,
R.Ashfield,
S.B.Clemmensen,
W.A.De jongh,
S.J.Draper,
M.K.Higgins.
|
 |
|
Ref.
|
 |
Nature, 2014,
515,
427-430.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Invasion of host erythrocytes is essential to the life cycle of Plasmodium
parasites and development of the pathology of malaria. The stages of erythrocyte
invasion, including initial contact, apical reorientation, junction formation,
and active invagination, are directed by coordinated release of specialized
apical organelles and their parasite protein contents. Among these proteins, and
central to invasion by all species, are two parasite protein families, the
reticulocyte-binding protein homologue (RH) and erythrocyte-binding like
proteins, which mediate host-parasite interactions. RH5 from Plasmodium
falciparum (PfRH5) is the only member of either family demonstrated to be
necessary for erythrocyte invasion in all tested strains, through its
interaction with the erythrocyte surface protein basigin (also known as CD147
and EMMPRIN). Antibodies targeting PfRH5 or basigin efficiently block parasite
invasion in vitro, making PfRH5 an excellent vaccine candidate. Here we present
crystal structures of PfRH5 in complex with basigin and two distinct inhibitory
antibodies. PfRH5 adopts a novel fold in which two three-helical bundles come
together in a kite-like architecture, presenting binding sites for basigin and
inhibitory antibodies at one tip. This provides the first structural insight
into erythrocyte binding by the Plasmodium RH protein family and identifies
novel inhibitory epitopes to guide design of a new generation of vaccines
against the blood-stage parasite.
|
 |
|
|
|
|
 |